The "Hormones in Dosage Except Contraceptives and Antibiotics" market in Guatemala reached a value of 63.746 million USD in 2023. This represented a slight increase from the previous year, with a year-on-year growth rate of 2.71%. Over the last five years, the market demonstrated a compound annual growth rate (CAGR) of 3%. The market has shown mixed trends, including growth spurts and regressions, indicating varied demand dynamics.
In the future, closely watch for shifts in healthcare policies, potential supply chain disruptions, and technological advancements in hormone therapies, which could significantly impact market dynamics and consumer behavior.
